Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?

Detalles Bibliográficos
Autores principales: Gérard, Alexandre O., Laurain, Audrey, Favre, Guillaume, Drici, Milou-Daniel, Esnault, Vincent L.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
e-Letters – Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862288/
https://www.ncbi.nlm.nih.gov/pubmed/35973076
http://dx.doi.org/10.2337/dc22-0921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862288/
https://www.ncbi.nlm.nih.gov/pubmed/35973076
http://dx.doi.org/10.2337/dc22-0921

Ejemplares similares